Bidart J M
Service d'Immunologie Moléculaire, Institut Gustave-Roussy, Villejuif.
Ann Pharm Fr. 1994;52(1):1-10.
Most of the available information on the structure-function of gonadotropins is critical for the development of both therapeutic approaches to reproductive malfunctions and new strategies for the control of fertility. Major advances in our understanding of the structure of these hormones and the manner in which they interact with their receptors have been made in recent years. Furthermore, the recent availability of highly purified hormones and their recombinant counterparts as well as the cloning of he receptors offer new tools for the investigation of structure-activity relationship of gonadotropins. The present article reviews: (i) the overall structure of these complex glycoprotein hormones assembled from two distinct alpha (alpha) and beta (beta) subunits, (ii) their heterogeneities in term of carbohydrate and peptidic structures, which influence both the bioactivity and the immunoreactivity of the hormones, (iii) the structure and the functional domains of their receptors, belonging to the G-protein coupled receptor family, and (iv) the more recent information available on the regions of interaction between the subunits and between the hormone and its corresponding receptor. Pioneering work on the topographical features of gonadotropins has been accomplished in a piecemeal fashion by using classic chemical methods of protein modification. In the last ten years, new approaches, including the production of monoclonal antibodies, the construction of synthetic peptides and the use of recombinant DNA technology, provided important insights in the knowledge of these molecules. However, significant progress remains to be accomplished, particularly in the establishment of the three-dimensional structure of these hormones, which are critical for the understanding of pathophysiological processes related to endocrinology and for the design of new peptidic or nonpeptidic analogs useful of therapeutic approaches.
目前有关促性腺激素结构与功能的大部分信息,对于生殖功能障碍治疗方法的开发以及生育控制新策略的制定都至关重要。近年来,我们在理解这些激素的结构以及它们与受体相互作用方式方面取得了重大进展。此外,近期高纯度激素及其重组类似物的可得性,以及受体的克隆,为研究促性腺激素的构效关系提供了新工具。本文综述了:(i)这些由两个不同的α(α)和β(β)亚基组装而成的复杂糖蛋白激素的整体结构;(ii)它们在碳水化合物和肽结构方面的异质性,这会影响激素的生物活性和免疫反应性;(iii)其受体的结构和功能域,这些受体属于G蛋白偶联受体家族;(iv)关于亚基之间以及激素与其相应受体之间相互作用区域的最新信息。关于促性腺激素拓扑特征的开创性工作是通过使用经典的蛋白质修饰化学方法逐步完成的。在过去十年中,新方法,包括单克隆抗体的产生、合成肽的构建以及重组DNA技术的应用,为了解这些分子提供了重要见解。然而,仍有待取得重大进展,特别是在确定这些激素的三维结构方面,这对于理解与内分泌学相关的病理生理过程以及设计用于治疗方法的新型肽类或非肽类类似物至关重要。